Forbes October 15, 2025
In this week’s edition of InnovationRx, we look at the Khosla Ventures-Cleveland Clinic partnership, Town Hall Ventures’ $440 million haul, the CDC’s “Friday night massacre,” Boehringer’s new pulmonary fibrosis drug, and more.
New technologies are transforming the way that hospitals operate. To try and gain an edge, Khosla Ventures and Cleveland Clinic signed a deal in which the health system will test new technologies that span AI, digital health and next-generation therapeutics from the VC firm’s portfolio companies—and the two will explore opportunities to incubate new companies together.
“I think this is a novel approach,” Hal Paz, Khosla Ventures’ operating partner, told Forbes.
Discussions that led to the agreement, announced at Cleveland Clinic’s Life Sciences Summit in London on Tuesday,...
Today's Sponsors
Today's Sponsor